Michael Rassner

655 total citations
20 papers, 187 citations indexed

About

Michael Rassner is a scholar working on Hematology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Rassner has authored 20 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Rassner's work include Multiple Myeloma Research and Treatments (8 papers), Neuroscience and Neuropharmacology Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Michael Rassner is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Neuroscience and Neuropharmacology Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Michael Rassner collaborates with scholars based in Germany, United States and Austria. Michael Rassner's co-authors include Thomas J. Feuerstein, Thomas M. Freiman, Marie Follo, Monika Engelhardt, Ralph Wäsch, Nikolas von Bubnoff, Justus Duyster, Andréas Mackensen, Mario Schiffer and Johanna Schneider and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Michael Rassner

16 papers receiving 187 citations

Peers

Michael Rassner
Sara Lewis United States
Nicola J. Weston-Bell United Kingdom
Raphael M. Buzzi Switzerland
Carolyn Paul United Kingdom
Carson Flamm United States
Kuo Sc Taiwan
Manu Pandey United States
Sara Lewis United States
Michael Rassner
Citations per year, relative to Michael Rassner Michael Rassner (= 1×) peers Sara Lewis

Countries citing papers authored by Michael Rassner

Since Specialization
Citations

This map shows the geographic impact of Michael Rassner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rassner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rassner more than expected).

Fields of papers citing papers by Michael Rassner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rassner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rassner. The network helps show where Michael Rassner may publish in the future.

Co-authorship network of co-authors of Michael Rassner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rassner. A scholar is included among the top collaborators of Michael Rassner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rassner. Michael Rassner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rassner, Michael, Burkhard Schmidt, Sebastian Theurich, et al.. (2025). Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers. Haematologica.
3.
Rassner, Michael, Tony Andreas Müller, Geoffroy Andrieux, et al.. (2024). STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment. Blood. 144(Supplement 1). 4119–4119.
5.
Rassner, Michael, Marie Follo, Stefanie Jilg, et al.. (2023). Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST). International Journal of Molecular Sciences. 24(6). 5411–5411. 1 indexed citations
6.
Frank, Benedikt, Gabriele Ihorst, Georg W. Herget, et al.. (2022). Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers. Annals of Hematology. 102(3). 603–611. 4 indexed citations
7.
Rassner, Michael, Ralph Wäsch, Mario Schiffer, et al.. (2021). Two cases of carfilzomib‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. BMC Nephrology. 22(1). 32–32. 18 indexed citations
8.
Dold, Sandra Maria, Dagmar Wider, Marie Follo, et al.. (2021). Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients. Frontiers in Oncology. 11. 708231–708231. 7 indexed citations
9.
Müller, Tony Andreas, Michael Rassner, Jan Mitschke, et al.. (2021). Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR. International Journal of Molecular Sciences. 22(21). 11649–11649. 1 indexed citations
10.
Rassner, Michael, Johannes Jung, Johanna Schneider, Ralph Wäsch, & Monika Engelhardt. (2020). Dapsone-Induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses. Clinical Lymphoma Myeloma & Leukemia. 20(11). e821–e825. 1 indexed citations
11.
Rassner, Michael, Marie Follo, Geoffroy Andrieux, et al.. (2020). CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML. Molecular Oncology. 14(4). 779–794. 25 indexed citations
12.
Herget, Georg W., Felix Kälberer, Gabriele Ihorst, et al.. (2020). Interdisciplinary approach to multiple myeloma – time to diagnosis and warning signs. Leukemia & lymphoma. 62(4). 891–898. 8 indexed citations
13.
Wehrle, Julius, Marie Follo, Saskia Hussung, et al.. (2020). Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management. Diagnostics. 10(8). 550–550. 8 indexed citations
14.
Jilg, Stefanie, Michael Rassner, Jacqueline Maier, et al.. (2019). Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST). International Journal of Cancer. 145(8). 2292–2303. 25 indexed citations
15.
Rassner, Michael, Maximilian Seidl, Ulrich Salzer, et al.. (2017). Cast Nephropathy and Deceptively Low Absolute Serum Free Light Chain Levels: Resolution of a Challenging Case and Systematic Review of the Literature. Clinical Lymphoma Myeloma & Leukemia. 18(1). e1–e7. 2 indexed citations
16.
Rassner, Michael, et al.. (2016). Neocortical GABA release at high intracellular sodium and low extracellular calcium: an anti‐seizure mechanism. Journal of Neurochemistry. 137(2). 177–189. 12 indexed citations
17.
Rassner, Michael, et al.. (2015). Reduction of epileptiform activity through local valproate-implants in a rat neocortical epilepsy model. Seizure. 30. 6–13. 5 indexed citations
18.
Rassner, Michael, et al.. (2013). Altered transporter‐mediated neocortical GABA release in Rasmussen encephalitis. Epilepsia. 54(3). e41–4. 7 indexed citations
19.
Altenmüller, Dirk‐Matthias, et al.. (2013). Locally Applied Valproate Enhances Survival in Rats after Neocortical Treatment with Tetanus Toxin and Cobalt Chloride. BioMed Research International. 2013. 1–9. 5 indexed citations
20.
Rassner, Michael, et al.. (2011). Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes. Naunyn-Schmiedeberg s Archives of Pharmacology. 384(1). 47–57. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026